References Sean Wharton et al, Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomized, controlled, phase 3b trial, The Lancet Diabetes and Endocrinology, Volume 13, Issue 11p949-963November 2025, DOI: 10.1016/S2213-8587(25)00226-8 Higher dose of semaglutide provided average weight loss of 21% in people with obesity with a third achieving 25% or more according to data presented at ADA, Press Release, and Novo Nordisk Wharton, S, et al
Neuronal dysregulation in the hypothalamus is a major pathological hallmark of obesity 7
If injectable tirzepatide triggers anxiety in your case, PlexusDx offers alternative formulations like Oral Tirzepatide or the Microdose GLP-1 Protocol, each engineered to minimize unwanted mood effects
There is currently no official contraindication listed in the Mounjaro Summary of Product Characteristics (SmPC) that specifically prohibits the concurrent use of cannabis
Semaglutide GLP-1 offers a unique approach by interacting with the brain and pancreas to suppress hunger and promote satiety
35 JiaB.SunM.SunX.LiR.WangZ.WuJ.et al (2016)